Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-5,255
Closed -$353K 155
2017
Q3
$353K Hold
5,255
0.03% 152
2017
Q2
$315K Sell
5,255
-2,995
-36% -$193K 0.02% 155
2017
Q1
$546K Hold
8,250
0.04% 129
2016
Q4
$582K Hold
8,250
0.06% 133
2016
Q3
$469K Hold
8,250
0.05% 132
2016
Q2
$344K Hold
8,250
0.04% 143
2016
Q1
$290K Hold
8,250
0.04% 147
2015
Q4
$267K Hold
8,250
0.03% 152
2015
Q3
$286K Hold
8,250
0.04% 141
2015
Q2
$333K Hold
8,250
0.04% 147
2015
Q1
$298K Hold
8,250
0.04% 154
2014
Q4
$278K Hold
8,250
0.03% 164
2014
Q3
$275K Buy
+8,250
New +$303K 0.03% 164

Other funds holding AGX

Oak Associates's AGX Position: Q4 2017 in Review

Oak Associates sold out of Argan (AGX) in Q4 2017, closing a stake of 5,255 shares — an estimated $353K sold.

Oak Associates first reported a position in AGX in Q3 2014 and held it in 13 quarters. The position peaked at $582K in Q4 2016. 173 funds tracked by Wall St. Rank hold AGX as of Q4 2017.

  • Oak Associates reported no remaining Argan position as of Q4 2017 after selling out during the quarter.
  • Oak Associates sold 5,255 Argan shares in Q4 2017, an estimated $353K.
  • Oak Associates first reported a position in Argan in Q3 2014 and held it in 13 quarters.
  • Oak Associates's Argan position peaked at $582K in Q4 2016.
  • 173 funds tracked by Wall St. Rank held Argan as of Q4 2017.

Based on Oak Associates's 13F filing for Q4 2017, filed 8 Feb 2018.